Form 4 Tracker
Kristin Abate

Chief Accounting Officer · 6 filings · Latest: Oct 1, 2026

Karyopharm Therapeutics Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
KPTI
Kristin AbateChief Accounting OfficerOct 1, 2026
Sale
$1.19378$45023,404
KPTI
Kristin AbateChief Accounting OfficerSep 1, 2026
Sale
$2.0219$3823,782
KPTI
Kristin AbateChief Accounting OfficerMay 14, 2026
Sale
$9.5053$50423,801
KPTI
Kristin AbateChief Accounting OfficerMar 2, 2026
Sale
$9.41559$5.3K22,063
KPTI
Kristin AbateChief Accounting OfficerJan 28, 2026
Sale
$7.0350$35222,622
KPTI
Kristin AbateChief Accounting OfficerJan 21, 2026
Sale
$5.96265$1.6K22,580